BerGenBio’s Bemcentinib Shows Promise in Lung Cancer Study
PremiumCompany AnnouncementsBerGenBio’s Bemcentinib Shows Promise in Lung Cancer Study
1M ago
BerGenBio ASA Announces Virtual Extraordinary Meeting
Premium
Company Announcements
BerGenBio ASA Announces Virtual Extraordinary Meeting
2M ago
BerGenBio ASA Presents at Global Investment Conference
Premium
Company Announcements
BerGenBio ASA Presents at Global Investment Conference
2M ago
BerGenBio Completes Share Capital Reduction
PremiumCompany AnnouncementsBerGenBio Completes Share Capital Reduction
3M ago
BerGenBio ASA Announces Upcoming Financial Results
Premium
Company Announcements
BerGenBio ASA Announces Upcoming Financial Results
3M ago
BerGenBio Advances with Phase 2a NSCLC Trial
Premium
Company Announcements
BerGenBio Advances with Phase 2a NSCLC Trial
4M ago
BRRGF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBRRGF Upcoming Earnings Report: What to Expect?
9M ago
BerGenBio downgraded to Sell on ‘detrimental’ financing at DNB
Premium
The Fly
BerGenBio downgraded to Sell on ‘detrimental’ financing at DNB
2y ago
BerGenBio downgraded to Sell from Hold at DNB Markets
Premium
The Fly
BerGenBio downgraded to Sell from Hold at DNB Markets
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100